-
Mashup Score: 0Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus - 6 month(s) ago
Objective Concerns about the affordability of medications are common in systemic lupus erythematosus (SLE), but the relationship between medication cost concerns and health outcomes is poorly understood. We assessed the association of self-reported medication cost concerns and patient-reported outcomes (PROs) in a multiethnic SLE cohort. Methods The California Lupus Epidemiology Study is a cohort of individuals with physician-confirmed SLE. Medication cost concerns were defined as having difficulties affording SLE medications, skipping doses, delaying refills, requesting lower-cost alternatives, purchasing medications outside the United States, or applying for patient assistance programs. Linear regression and mixed effects models assessed the cross-sectional and longitudinal association of medication cost concerns and PROs, respectively, adjusting for age, sex, race and ethnicity, income, principal insurance, immunomodulatory medications, and organ damage. Results Of 334 participants,
Source: www.jrheum.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
‘Women think they are insured until they get a diagnosis,’ says the author of a new paper.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Cancer patients who receive prescriptions for biosimilars, generics, and clinically appropriate lower-cost drugs instead of established, costlier drugs can reduce the total cost of care by 5% or more and maintain quality of care: https://t.co/t3ljFVpfpa #drugcosts #healthcare https://t.co/IS8WBAXTfp
-
-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Cancer patients who receive prescriptions for biosimilars, generics, and clinically appropriate lower-cost drugs instead of established, costlier drugs can reduce the total cost of care by 5% or more and maintain quality of care: https://t.co/t3ljFVpfpa #drugcosts #healthcare https://t.co/FKQFVDFKnb
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Cancer patients who receive prescriptions for biosimilars, generics, and clinically appropriate lower-cost drugs instead of established, costlier drugs can reduce the total cost of care by 5% or more and maintain quality of care: https://t.co/t3ljFV7E0A #drugcosts #healthcare https://t.co/lBa0peuQcy
-
-
Mashup Score: 0Biden signs massive climate and healthcare legislation - 2 year(s) ago
The legislation would cap prescription drug costs at $2,000 out-of-pocket annually for Medicare recipients.
Source: Modern HealthcareCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
77 views, 5 likes, 3 loves, 4 comments, 1 shares, Facebook Watch Videos from Andrew Schorr: The U.S. Senate passed it! So will the House. What could lower drug prices mean for you and when? Esther…
Source: www.facebook.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 7Supreme Court denies ERISA suit against Anthem, Express Scripts - 2 year(s) ago
Self-insured employers and some workers sued, alleging the companies had a fiduciary responsibility to reduce their drug costs.
Source: Modern HealthcareCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3
Express Scripts allegedly inflated drug costs for payers and patients through the pharmacy benefit manager’s auto-refill dispensing scheme.
Source: Modern HealthcareCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 10Medicare could save $3.6B buying generic drugs at Mark Cuban pharmacy’s prices: study - 2 year(s) ago
Medicare could have saved up to $3.6 billion in 2020 if it bought generic drugs at the prices paid by billionaire entrepreneur Mark Cuban’s drug company, according to a new study.  The study …
Source: The HillCategories: Future of Medicine, Latest HeadlinesTweet
Research Article Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus 📰 https://t.co/GlXr9kbHCe #drugcosts #healthcare #disparities #patients #lupus https://t.co/fj7X1LQyvk